MARIE ALTIERI: Open Payments
NPI 1801103221 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,178 in 67 payments from 19 companies in 2025. Trend: 2023 $1,378 · 2024 $1,959 · 2025 $2,178
Food & beverage: $2,145Education: $32
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $452 |
| Novo Nordisk Inc | 8 | $357 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $227 |
| Novartis Pharmaceuticals Corporation | 18 | $208 |
| Esperion Therapeutics, Inc. | 5 | $204 |
| PFIZER INC. | 3 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Boston Scientific Corporation | 2 | $48 |
Products named: Korlym, Wegovy, JARDIANCE, NEXLETOL, LEQVIO, Ozempic, XIFAXAN, VYNDAQEL.
Industry payments across FL — which companies pay providers there.
